cp wire

CP Wire Articles

Evotec AG (OTC PINK: EVTCY) (FSE: EVTA) (XETRA: EVT) announced on 2/28/19 that a promising small molecule from its multi-target alliance with Bayer has advanced into Phase II clinical development... read more

Thu, 02/28/19 - 10:35 am

Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new biopharmaceutical company focused on advancing next-generation targeted therapies for high-risk... read more

Wed, 02/27/19 - 10:14 am

This morning, starting at approximately 10:15 AM ET, the United States Senate Finance Committee is holding a special hearing on drug pricing. Going before the Committee will be seven... read more

Tue, 02/26/19 - 10:20 am

Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp. (Nasdaq: BCAC) jointly announced on 2/25/19 the dosing of the first South Korean... read more

Tue, 02/26/19 - 10:02 am

Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) announced on 2/25/19 that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for... read more

Mon, 02/25/19 - 10:16 am

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced on 2/25/19 that given the increasing viability of Valve-in-Valve (ViV) procedures, it has added new safety and... read more

Mon, 02/25/19 - 09:58 am

Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced on 2/21/19 that the U.S. Food and Drug Administration (FDA)... read more

Fri, 02/22/19 - 09:46 am

On 2/21/19 Outlook Therapeutics filed for a $57 million offering in part to support its treatment for wet AMD (age related macular degeneration). The filing did not specify the number of shares to... read more

Thu, 02/21/19 - 10:49 am

SkinBioTherapeutics to Seeking New CEO
On 2/14/19 SkinBioTherapeutics... read more

Wed, 02/20/19 - 02:23 pm

Pfizer’s Xeljanz (tofacitinib), used to treat conditions such as rheumatoid arthritis and ulcerative colitis, has... read more
Wed, 02/20/19 - 11:50 am

On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of  common stock. The expected price is between $20 and $22 per share. The shares will be... read more

Tue, 02/19/19 - 09:53 am

CStone Pharmaceuticals is seeking to raise $282 Million in its upcoming Hong Kong IPO. The company's investors include Boyu Capital, Sequoia Capital, Oriza Holdings, and GIC.

The company... read more

Mon, 02/18/19 - 09:48 am

5AM Venture Management, LLC (5AM) of San Francisco, CA and Boston, MA announced on 2/13/19 the closing of two new venture capital funds, totaling $497 million in committed capital. The capital was... read more

Thu, 02/14/19 - 09:53 am

Cirius Therapeutics has updated it filing for a planned $86 million IPO. The date of the IPO still hasn't been set.

Cirius' lead candidate, MSDC-0602K, is a once daily, oral treatment for... read more

Thu, 02/14/19 - 09:38 am

Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announced on 2/13/19 that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an... read more

Wed, 02/13/19 - 05:02 pm

Beginning on March 1, China will reduce the VAT on a group of 21 rare disease drugs from 16% to 3%. The government's announcement did not specify which drugs would be in the group. The move may... read more

Wed, 02/13/19 - 09:38 am

Yuhan Corporation (000100.KS; Yuhan) and Sorrento Therapeutics (Nasdaq: SRNE) announced on 2/12/19 that ImmuneOncia, a joint venture formed in September 2016, has completed a private equity... read more

Tue, 02/12/19 - 09:55 am

Xeris Pharmaceuticals announced on 2/11/19 that it filed a registration statement with the Securities and Exchange Commission (the “SEC”) relating to a proposed public offering of 5,000,000 shares... read more

Tue, 02/12/19 - 09:41 am

Seattle Genetics (Nasdaq:SGEN) announced on 2/11/19 that its collaborator, Takeda Pharmaceutical Company Limited, received approval from the European Commission to extend the marketing... read more

Mon, 02/11/19 - 10:11 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.